John Peter Warr

Title: John Peter Warr: Innovator in Pharmaceutical Processes

Introduction

John Peter Warr is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for milling poorly soluble drugs. With a total of 3 patents to his name, Warr's work has had a considerable impact on drug formulation techniques.

Latest Patents

Warr's latest patents include a process for milling poorly soluble drugs in the presence of liquid propellants. This innovative method allows for the preparation of drug substances that can be co-milled with a pharmaceutically acceptable polymer in a liquid propellant. Another notable patent describes a wet granulation process where a pharmaceutical substance is granulated using a halogenated hydrocarbon with a normal boiling point below ambient temperature. This process is conducted under pressure to maintain the halogenated hydrocarbon in a liquid state, and it also includes a recycling method for the halogenated hydrocarbon.

Career Highlights

Throughout his career, John Peter Warr has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and Glaxo Group Limited. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and processes.

Collaborations

Warr has collaborated with several notable individuals in his field, including Christopher Edmund Valder and David Roy Merrifield. These collaborations have likely enriched his work and expanded the scope of his innovations.

Conclusion

John Peter Warr's contributions to pharmaceutical processes demonstrate his commitment to advancing drug formulation techniques. His innovative patents and collaborations highlight his role as a significant figure in the industry.